Zhao Weixing, Steinfeld Justin B, Liang Fengshan, Chen Xiaoyong, Maranon David G, Jian Ma Chu, Kwon Youngho, Rao Timsi, Wang Weibin, Sheng Chen, Song Xuemei, Deng Yanhong, Jimenez-Sainz Judit, Lu Lucy, Jensen Ryan B, Xiong Yong, Kupfer Gary M, Wiese Claudia, Greene Eric C, Sung Patrick
Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Department of Biochemistry & Molecular Biophysics, Columbia University, New York, New York 10032, USA.
Nature. 2017 Oct 19;550(7676):360-365. doi: 10.1038/nature24060. Epub 2017 Oct 4.
The tumour suppressor complex BRCA1-BARD1 functions in the repair of DNA double-stranded breaks by homologous recombination. During this process, BRCA1-BARD1 facilitates the nucleolytic resection of DNA ends to generate a single-stranded template for the recruitment of another tumour suppressor complex, BRCA2-PALB2, and the recombinase RAD51. Here, by examining purified wild-type and mutant BRCA1-BARD1, we show that both BRCA1 and BARD1 bind DNA and interact with RAD51, and that BRCA1-BARD1 enhances the recombinase activity of RAD51. Mechanistically, BRCA1-BARD1 promotes the assembly of the synaptic complex, an essential intermediate in RAD51-mediated DNA joint formation. We provide evidence that BRCA1 and BARD1 are indispensable for RAD51 stimulation. Notably, BRCA1-BARD1 mutants with weakened RAD51 interactions show compromised DNA joint formation and impaired mediation of homologous recombination and DNA repair in cells. Our results identify a late role of BRCA1-BARD1 in homologous recombination, an attribute of the tumour suppressor complex that could be targeted in cancer therapy.
肿瘤抑制复合物BRCA1 - BARD1通过同源重组参与DNA双链断裂的修复过程。在此过程中,BRCA1 - BARD1促进DNA末端的核酸酶切切除,以生成单链模板,用于招募另一种肿瘤抑制复合物BRCA2 - PALB2和重组酶RAD51。在这里,通过检测纯化的野生型和突变型BRCA1 - BARD1,我们发现BRCA1和BARD1都能结合DNA并与RAD51相互作用,而且BRCA1 - BARD1能增强RAD51的重组酶活性。从机制上来说,BRCA1 - BARD1促进突触复合物的组装,这是RAD51介导的DNA连接形成过程中的一个关键中间体。我们提供的证据表明,BRCA1和BARD1对于刺激RAD51是不可或缺的。值得注意的是,与RAD51相互作用减弱的BRCA1 - BARD1突变体在细胞中显示出DNA连接形成受损以及同源重组和DNA修复介导功能受损。我们的研究结果确定了BRCA1 - BARD1在同源重组中的后期作用,这是该肿瘤抑制复合物的一个特性,有望成为癌症治疗的靶点。